(Updated - March 21, 2023 6:40 AM EDT)

Guggenheim analyst Michael Schmidt upgraded ORIC Pharamceuticals (NASDAQ: ORIC) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE